Assessing the benefits of antiretroviral therapy

被引:6
作者
Gulick, RM [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Cornell Clin Trials Unit, New York, NY 10021 USA
关键词
D O I
10.7326/0003-4819-133-6-200009190-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:471 / 473
页数:3
相关论文
共 20 条
  • [1] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
    Cameron, DW
    Heath-Chiozzi, M
    Danner, S
    Cohen, C
    Kravcik, S
    Maurath, C
    Sun, E
    Henry, D
    Rode, R
    Potthoff, A
    Leonard, J
    [J]. LANCET, 1998, 351 (9102) : 543 - 549
  • [2] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
    Carpenter, CCJ
    Cooper, DA
    Fischl, MA
    Gatell, JM
    Gazzard, BG
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schechter, M
    Schooley, RT
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03): : 381 - 390
  • [3] *CLIN PRACT TREATM, 2000, GUID US ANT AG HIV I
  • [4] Coffin JM, 1996, AIDS, V10, pS75
  • [5] Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
    Condra, JH
    Holder, DJ
    Schleif, WA
    Blahy, OM
    Danovich, RM
    Gabryelski, LJ
    Graham, DJ
    Laird, D
    Quintero, JC
    Rhodes, A
    Robbins, HL
    Roth, E
    Shivaprakash, M
    Yang, T
    Chodakewitz, JA
    Deutsch, PJ
    Leavitt, RY
    Massari, FE
    Mellors, JW
    Squires, KE
    Steigbigel, RT
    Teppler, H
    Emini, EA
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8270 - 8276
  • [6] Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
    Deeks, SG
    Barbour, JD
    Martin, JN
    Swanson, MS
    Grant, RM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) : 946 - 953
  • [7] DEEKS SG, 2000, 7 C RETR OPP INF 30, P120
  • [8] THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    FAHEY, JL
    TAYLOR, JMG
    DETELS, R
    HOFMANN, B
    MELMED, R
    NISHANIAN, P
    GIORGI, JV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) : 166 - 172
  • [9] Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy
    Grabar, S
    Le Moing, V
    Goujard, C
    Leport, C
    Kazatchkine, MD
    Costagliola, D
    Weiss, L
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 401 - 410
  • [10] 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine
    Gulick, RM
    Mellors, JW
    Havlir, D
    Eron, JJ
    Meibohm, A
    Condra, JH
    Valentine, FT
    McMahon, D
    Gonzalez, C
    Jonas, L
    Emini, EA
    Chodakewitz, JA
    Isaacs, R
    Richman, DD
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) : 35 - 39